Finance

Lists
B1SX34:BVMF
Boston Scientific Corp Brazilian Depositary Receipt
54,75 R$
0,00%
(0,00) 1D
13 հոկ, 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for B1SX34...
Open
55,60 R$
High
56,09 R$
Low
53,20 R$
Mkt. cap
62,77 մլրդ
Avg. vol.
1,02 հզր
Volume
2,02 հզր
52-wk high
140,91 R$
52-wk low
50,29 R$
Shares outstanding
1,45 մլրդ
No. of employees
59 հզր
Open
55,60 R$
High
56,09 R$
Low
53,20 R$
Mkt. cap
62,77 մլրդ
Avg. vol.
1,02 հզր
Volume
2,02 հզր
52-wk high
140,91 R$
52-wk low
50,29 R$
Shares outstanding
1,45 մլրդ
No. of employees
59 հզր
News stories
From web sources and news partners
Profile
Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. The company is known for developing the Taxus Stent, a drug-eluting stent that is used to open clogged arteries. BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware. Wikipedia
About Boston Scientific Corp Brazilian Depositary Receipt
CEOMichael F. Mahoney
Employees59 հզր
Founded29 հնս, 1979 թ.
HeadquartersMarlborough, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
5,06 մլրդ
5,29 մլրդ
5,20 մլրդ
5,44 մլրդ
Cost of goods sold
1,54 մլրդ
1,61 մլրդ
1,60 մլրդ
1,61 մլրդ
Cost of revenue
1,54 մլրդ
1,61 մլրդ
1,60 մլրդ
1,61 մլրդ
Research and development expenses
514,00 մլն
569,00 մլն
516,00 մլն
554,00 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,74 մլրդ
1,83 մլրդ
1,78 մլրդ
1,80 մլրդ
Operating expense
2,48 մլրդ
2,63 մլրդ
2,53 մլրդ
2,59 մլրդ
Total operating expenses
4,02 մլրդ
4,24 մլրդ
4,13 մլրդ
4,20 մլրդ
Operating income
1,05 մլրդ
1,04 մլրդ
1,07 մլրդ
1,25 մլրդ
Other non operating income
-16,00 մլն
28,00 մլն
28,00 մլն
-6,00 մլն
EBT including unusual items
938,00 մլն
700,00 մլն
1,16 մլրդ
1,06 մլրդ
EBT excluding unusual items
935,00 մլն
1,01 մլրդ
999,00 մլն
1,14 մլրդ
Income tax expense
183,00 մլն
30,00 մլն
-176,00 մլն
155,00 մլն
Effective tax rate
19,51%
4,29%
-15,13%
14,62%
Other operating expenses
-
-
-
-
Net income
755,00 մլն
672,00 մլն
1,34 մլրդ
907,00 մլն
Net profit margin
14,91%
12,71%
25,77%
16,67%
Earnings per share
0,75
0,80
0,80
0,86
Interest and investment income
-
29,00 մլն
-
11,00 մլն
Interest expense
-87,00 մլն
-90,00 մլն
-90,00 մլն
-96,00 մլն
Net interest expenses
-87,00 մլն
-61,00 մլն
-90,00 մլն
-85,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
1,39 մլրդ
1,41 մլրդ
1,42 մլրդ
1,60 մլրդ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps